|
Oct 25
|
Astrazeneca (AZN) Stock Moves -0.56%: What You Should Know
|
|
Oct 25
|
PRESS DIGEST-British Business - Oct 25
|
|
Oct 24
|
AstraZeneca asks the FDA to let adults give themselves the annual flu vaccine
|
|
Oct 24
|
US Food and Drug Administration accepts for review AstraZeneca’s Supplemental Biologics License Application for self-administration of FLUMIST® QUADRIVALENT (Influenza Vaccine Live, Intranasal)
|
|
Oct 24
|
Alexion, AstraZeneca Rare Disease, concludes Letter of Intent (LOI) with the pan-Canadian Pharmaceutical Alliance (pCPA) for Ultomiris for the treatment of patients with paroxysmal nocturnal hemoglobinuria or atypical hemolytic uremic syndrome
|
|
Oct 24
|
US FDA accepts AstraZeneca's self-administered flu vaccine for review
|
|
Oct 23
|
Datopotamab deruxtecan improved progression-free survival vs. chemotherapy in patients with previously treated non-small cell lung cancer in TROPION-Lung01 Phase III trial
|
|
Oct 23
|
ENHERTU® (fam-trastuzumab deruxtecan-nxki) Demonstrated Clinically Meaningful Survival Across Multiple HER2-Expressing Advanced Solid Tumors in DESTINY-PanTumor02 Phase II Trial
|
|
Oct 23
|
AstraZeneca hails ‘clinically meaningful’ cancer drug trial results
|
|
Oct 23
|
Datopotamab deruxtecan significantly extended progression-free survival vs. chemotherapy in patients with HR-positive, HER2-low or negative breast cancer in TROPION-Breast01 Phase III trial
|
|
Oct 23
|
AstraZeneca PLC's (LON:AZN) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
|
|
Oct 23
|
Merck (MRK) to Report Q3 Earnings: What's in the Cards?
|
|
Oct 23
|
AbbVie (ABBV) to Report Q3 Earnings: What's in the Cards?
|
|
Sep 4
|
Here is What to Know Beyond Why AstraZeneca PLC (AZN) is a Trending Stock
|
|
Sep 2
|
8 Pharma Stocks Affected by New Drug Price Negotiation Rules
|
|
Aug 31
|
Why this S.F. company says Big Pharma deal is big win for patients
|
|
Aug 31
|
Big Pharma's biggest ally gets trolled on X for attacking Medicare drug pricing list
|
|
Aug 31
|
China's CanSino seeks more vaccine contracts after AstraZenca deal
|
|
Aug 31
|
CanSino Biologics on AstraZeneca Deal, Earnings
|
|
Aug 30
|
Medicare price negotiation list: What it means for pharma companies
|